What they were paid
Tarsus Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $2,889 | — | — | $0 | $2,889 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tarsus Pharmaceuticals, Inc. DEF 14A filed April 28, 2026, accession 0001819790-26-000028, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Tarsus Pharmaceuticals pays directors a $50,000 cash retainer and $241,728 in equity.
Committees
FY2025 · as the proxy prints themAudit · Commercial
The rest of the Tarsus Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Goldberg | Independent Director | $310,284 |
| Bhaskar Chaudhuri | Independent Director | $315,728 |
| Bobak Azamian | Chair of the Board | $0 |
| David E.I. Pyott | Independent Director | $0 |
| Katherine Goodrich | Independent Director | $306,728 |
| Scott Morrison | Independent Director | $316,728 |
| Wendy Yarno | Lead Independent Director | $394,339 |
| William J. Link | Independent Director | $313,228 |
The full Tarsus Pharmaceuticals compensation record
free company briefThis page is one director within Tarsus Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat